Karyopharm Therapeutics
KPTI
#9056
Rank
ยฃ99.27 M
Marketcap
ยฃ4.40
Share price
4.49%
Change (1 day)
62.29%
Change (1 year)

Market capitalization of Karyopharm Therapeutics (KPTI)

Market cap: ยฃ99.27 Million

As of April 2026 Karyopharm Therapeutics has a market cap of ยฃ99.27 Million. This makes Karyopharm Therapeutics the world's 9056th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Karyopharm Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ99.27 M5.39%
2025ยฃ94.19 M33.63%
2024ยฃ70.49 M-9.35%
2023ยฃ77.76 M-75.56%
2022ยฃ0.31 B-11.59%
2021ยฃ0.35 B-56.95%
2020ยฃ0.83 B-12.53%
2019ยฃ0.95 B112.83%
2018ยฃ0.44 B33.98%
2017ยฃ0.33 B6.66%
2016ยฃ0.31 B-2.02%
2015ยฃ0.32 B-59.21%
2014ยฃ0.78 B91.22%
2013ยฃ0.41 B

End of Day market cap according to different sources

On Apr 1st, 2026 the market cap of Karyopharm Therapeutics was reported to be:

ยฃ80.77 Million
by Nasdaq info icon info icon
ยฃ99.27 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
ยฃ134.60 B 135,495.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ226.05 B 227,612.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ95.36 B 95,962.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
ยฃ8.93 B 8,899.60%๐Ÿ‡บ๐Ÿ‡ธ USA